App-Quantinova.ai

Inhibition of S-Adenosylmethionine-dependent methyltransferase resists TGF-1-induced EMT of pancreatic cancer via microRNA alterations

Rajgopal Govindarajan - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Ademetionine

CtBP1 and metabolic syndrome modulate cell adhesion and target multiple miRNAs in breast cancer cells

Paola De Luca - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Suppression of miR-101a contributes to leukemogenesis by regulating epigenetic and pro-survival pathways in MLL AML stem cells

Estrella Gonzales-Aloy - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Nitric oxide stimulates expression of miRNA-155 through the BRCA1-dependent pathway

Justin Hawley - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

miR155

miR-142-3p is a candidate mediator of chloride intracellular channel 4 (CLIC4) loss during squamous cancer progression

Brandi L. Carofino - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Etoposide

Hippo pathway effectors YAP/TAZ integrate tissue mechanics and Wnt signaling to regulate microRNA biogenesis

Siyang Han - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

MiR182 mediated control over myeloid differentiation provides novel mechanism of Imatinib resistance in chronic myeloid leukemia

Deepak Arya - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Imatinib

Comprehensive long non-coding RNA expression profiling from the TCGA HNSCC RNA-sequencing data

Nijiro Nohata - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Dysregulation of lincRNAs is a major driver of aberrant epigenomes during tumorigenesis

Callie R. Merry - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The identification of p53 target genes and noncoding RNAs through the combined analysis of RNA-seq and ChIP-seq data

Masashi Idogawa - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Urinary cell-free microRNA panel in detection of urothelial carcinoma of the urinary bladder

Jaroslav Juracek - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

MiRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples

Michael Kent - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

miR-16

MicroRNA-137 is a putative predictive biomarker and can inhibit cell proliferation and induce apoptosis in colorectal cancer

YU-CHUAN HUANG - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Expression profiling, cellular and clinical implications of mitochondrial miRNAs in colorectal carcinomas

Faeza Ebrahimi - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

MiRNA and piRNA expression profiles in renal cell carcinoma tissue detected by next generation sequencing

Robert Iliev - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Mirnas hsa-miR-214-3p, -378a-3p e -34a-5p as biomarkers for uterine mesenchymal neoplasms

Laura G. dos Anjos - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

MicroRNA analysis paired with a novel live cell viability assay: a complete epigenetic workflow in human cancer cell lines

Samantha Lewis - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Identification of differentially expressed miRNAs of breast cancer among African American and European American women

Zhihong Gong - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies

Jing Shen - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Solid malignancies

N/A

miRNA differential profiling between fibroblasts originated from breast cancer and normal adjacent tissue from benign disease

Patricia Bortman Rozenchan - American Association for Cancer Research (AACR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Filters

41730 Abstracts